MedPath
FDA Approval

Clotrimazole and Betamethasone Dipropionate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Lake Erie Medical DBA Quality Care Products LLC
DUNS: 831276758
Effective Date
February 21, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Clotrimazole(10 mg in 1 g)
Betamethasone(0.5 mg in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Lake Erie Medical DBA Quality Care Products LLC

Lake Erie Medical DBA Quality Care Products LLC

831276758

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Clotrimazole and Betamethasone Dipropionate

Product Details

NDC Product Code
55700-524
Application Number
ANDA202894
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
June 6, 2017
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
CETOSTEARYL ALCOHOLInactive
Code: 2DMT128M1SClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
CETEARETH-30Inactive
Code: 1R9DCZ5FOXClass: IACT
PHOSPHORIC ACIDInactive
Code: E4GA8884NNClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
PETROLATUMInactive
Code: 4T6H12BN9UClass: IACT
Code: G07GZ97H65Class: ACTIBQuantity: 10 mg in 1 g
Code: 826Y60901UClass: ACTIMQuantity: 0.5 mg in 1 g
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACT
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RNClass: IACT
© Copyright 2025. All Rights Reserved by MedPath